<SEC-DOCUMENT>0002034679-25-000003-index.html : 20251010
<SEC-HEADER>0002034679-25-000003.hdr.sgml : 20251010
<ACCEPTANCE-DATETIME>20251010172320
ACCESSION NUMBER:		0002034679-25-000003
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20251009
FILED AS OF DATE:		20251010
DATE AS OF CHANGE:		20251010

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Raben David
		CENTRAL INDEX KEY:			0002034679
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42271
		FILM NUMBER:		251388773

	MAIL ADDRESS:	
		STREET 1:		BICARA THERAPEUTICS INC.
		STREET 2:		116 HUNTINGTON AVENUE, SUITE 703
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bicara Therapeutics Inc.
		CENTRAL INDEX KEY:			0002023658
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		116 HUNTINGTON AVENUE SUITE 703
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		617-468-4219

	MAIL ADDRESS:	
		STREET 1:		116 HUNTINGTON AVENUE SUITE 703
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>wk-form4_1760131397.xml
<DESCRIPTION>FORM 4
<TEXT>
Document 1 - file: wk-form4_1760131397.html

Document 1 - RAW XML: wk-form4_1760131397.xml

</DOCUMENT>
</SEC-DOCUMENT>